[(89)Zr]Zr-girentuximab for PET–CT imaging of clear-cell renal cell carcinoma: A prospective, open-label, multicentre, phase 3 trial Journal Article
| Authors: | Shuch, B.; Pantuck, A. J.; Bernhard, J. C.; Morris, M. A.; Master, V.; Scott, A. M.; van Praet, C.; Bailly, C.; Önal, B.; Aksoy, T.; Merkx, R.; Schuster, D. M.; Lee, S. T.; Pandit-Taskar, N.; Fan, A. C.; Allman, P.; Schmidt, K.; Tauchmanova, L.; Wheatcroft, M.; Behrenbruch, C. |
| Article Title: | [(89)Zr]Zr-girentuximab for PET–CT imaging of clear-cell renal cell carcinoma: A prospective, open-label, multicentre, phase 3 trial |
| Journal Title: | Lancet Oncology |
| Volume: | 25 |
| Issue: | 10 |
| ISSN: | 1470-2045 |
| Publisher: | Elsevier Science, Inc. |
| Date Published: | 2024-10-01 |
| Start Page: | 1277 |
| End Page: | 1287 |
| Language: | English |
| DOI: | 10.1016/s1470-2045(24)00402-9 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl plus with full text |
| PUBMED: | 39270701 |
| DOI/URL: | |
| Notes: | Accession Number: 179972852 -- Entry Date: In Process -- Revision Date: 20241003 -- Publication Type: Journal Article -- Journal Subset: Biomedical; Europe; Peer Reviewed; UK & Ireland -- NLM UID: 100957246. -- Source: CINAHL Plus with Full Text |
